Leigh MacMillan

March 20, 2025

Primary Care Autism Team honored for developing new care pathway

“This program dramatically improved continuity of care, implementation of best practices, and patient/provider education.”

By Leigh MacMillan

March 14, 2025

Blood formation and disorders expert Stuart Orkin to present Discovery Lecture March 27

Orkin’s research led to a gene therapy for sickle cell disease and beta-thalassemia; it is the first Food and Drug Administration-approved CRISPR-based gene therapy.

By Leigh MacMillan

March 12, 2025

Potential therapeutic for Duchenne muscular dystrophy takes step forward

Positive findings from a clinical trial support further study of the investigational drug ifetroban to treat cardiac complications, the leading cause of death in patients with DMD.

By Leigh MacMillan

March 10, 2025

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.

By Leigh MacMillan

February 3, 2025

Digital pathology aims to unlock secrets hidden in tissue samples

The pilot project, which is expected to digitize 500,000 slides over three years, aims to open avenues for research, assist with access to whole-slide images for education and clinical meetings (of tumor boards, for example), and facilitate planning for the implementation of digital pathology for diagnostic purposes.

By Leigh MacMillan (video by Erin O. Smith and Donn Jones)

January 23, 2025

Eric Skaar wins National Academy of Sciences award

Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases.”